20-year follow-up of the academic EORTC boost no-boost trial earns Best Abstract at ECC 2015
Results of a 20-year follow-up of the academic EORTC 22881-10882 [...]
EORTC and ESSO launch CLIMB for patients with unresectable colorectal liver metastases
Is it possible to cure patients with unresectable colorectal liver [...]
Will adjuvant pembrolizumab improve recurrence-free survival for patients with high-risk Stage III melanoma?
A recently opened double- blind phase III EORTC trial 1325 [...]
EORTC Presentations at ECC2015 in Vienna
The EORTC will have an active presence at this year’s [...]
Running Team to raise support for EORTC cancer research at Belfius Brussels Marathon
The EORTC Running Team plans to participate in the Belfius [...]
Dennis & Mireille Gillings Foundation Donates €1m to EORTC Cancer Research Fund
Will work with Walgreens Boots Alliance in supporting Biobank 6 [...]
Irradiation of regional nodes in four thousand stage I – III breast cancer patients affects overall survival
At a median follow-up of 10.9 years, an EORTC study [...]
PET adapted treatment improves outcome of patients with stages I/II Hodgkin Lymphoma
Final results of the randomized intergroup EORTC, LYSA (Lymphoma Study [...]
SPECTAlung: improving clinical trial access for patients with thoracic tumors
Hear Dr Jessica Menis and Dr Benjamin Besse to talk to [...]
Pazopanib improves progression-free survival without impairing health-related quality of life
Results of EORTC trial 62072 appearing in Cancer show that [...]
